endo-BCN-PEG4-Biotin: Usage Guidelines & Protocol

endo-BCN-PEG4-Biotin is a bifunctional bioorthogonal probe that combines an endo-bicyclo[6.1.0]nonyne (BCN) moiety for rapid, catalyst-free inverse electron-demand Diels-Alder (IEDDA) cycloaddition with tetrazine-bearing partners, a hydrophilic PEG4 spacer to enhance aqueous solubility and reduce nonspecific binding, and a biotin handle for high-affinity streptavidin-based detection or capture.

Reactive Group

endo-Bicyclo[6.1.0]nonyne (BCN) — reacts selectively with tetrazines via IEDDA cycloaddition

Detection Handle

Biotin — ultra-high affinity binding to streptavidin/avidin (Kd ~10⁻¹⁵ M)

Spacer

PEG4 (four ethylene glycol units) for improved aqueous solubility and reduced steric hindrance

Reaction Type

Bioorthogonal IEDDA click chemistry; no metal catalyst required; compatible with live cells and complex biological media

SKU

E1529528

Recommended Storage

Store at −20 °C, protected from light and moisture; aliquot to avoid freeze-thaw cycles

Mechanism of Action and Chemical Rationale

endo-BCN-PEG4-Biotin exploits the inverse electron-demand Diels-Alder (IEDDA) reaction, one of the fastest bioorthogonal chemistries known. The strained alkyne of the endo-BCN moiety acts as the dienophile, reacting selectively and rapidly with electron-poor tetrazine (Tz) dienes to form a stable dihydropyridazine adduct. Because neither BCN nor tetrazine reacts with endogenous cellular nucleophiles, thiols, or amines under physiological conditions, this chemistry is genuinely bioorthogonal.

The PEG4 spacer inserted between the BCN group and the biotin headgroup serves two purposes: (1) it increases the aqueous solubility of what would otherwise be a highly hydrophobic BCN-biotin conjugate, and (2) it provides conformational flexibility that ensures both functional ends of the molecule remain accessible to their respective binding partners — the tetrazine substrate and streptavidin.

The biotin terminus, upon ligation, can be detected or captured using streptavidin conjugated to fluorophores, enzymes (HRP, AP), magnetic beads, or agarose resins, leveraging the extremely high streptavidin–biotin affinity (Kd ≈ 10⁻¹⁵ M).

Recommended Protocol for Cell-Surface Bioorthogonal Labeling

Materials required: endo-BCN-PEG4-Biotin (E1529528), tetrazine-functionalized molecule of interest (e.g., Tz-antibody, Tz-small molecule, or genetically encoded Tz-amino acid), streptavidin detection reagent, phosphate-buffered saline (PBS, pH 7.4), DMSO (anhydrous).

Step 1 — Preparation of stock solution: Dissolve endo-BCN-PEG4-Biotin in anhydrous DMSO to prepare a 10–50 mM stock solution. Vortex gently and verify complete dissolution. Aliquot into single-use volumes and store at −20 °C. Avoid repeated freeze-thaw cycles to prevent hydrolysis or decomposition of the BCN moiety.

Step 2 — Introduction of tetrazine partner onto target: Label the biomolecule of interest with a tetrazine reagent according to the manufacturer's protocol (typically NHS-ester or maleimide chemistry). Remove excess tetrazine reagent by buffer exchange (spin column or dialysis). Confirm tetrazine incorporation by UV absorbance (Tz λmax ≈ 285 nm) or mass spectrometry.

Step 3 — IEDDA ligation: Dilute endo-BCN-PEG4-Biotin stock into PBS or cell-culture medium to a working concentration of 10–200 µM (optimize empirically). Add the tetrazine-bearing target. Allow the IEDDA reaction to proceed at room temperature (or 37 °C for live-cell applications) for 30–60 minutes. No catalyst, UV light, or elevated temperature is required.

Step 4 — Washing: For cell-surface applications, wash cells three times with PBS to remove unreacted probe. For in-solution ligation, remove excess reagent by size-exclusion chromatography or spin filtration.

Step 5 — Streptavidin-based detection: Apply streptavidin conjugate (fluorescent, enzymatic, or bead-based) according to the reagent manufacturer's protocol. Include appropriate blocking steps (e.g., 1% BSA in PBS) to minimize nonspecific binding. Analyze by flow cytometry, fluorescence microscopy, ELISA, Western blot, or affinity pull-down as appropriate.

Critical Parameters, Optimization, and Troubleshooting

Probe concentration: The optimal working concentration of endo-BCN-PEG4-Biotin depends on the abundance of the tetrazine target and the required signal-to-noise ratio. Begin with 50 µM and titrate. Excessively high concentrations may increase background streptavidin signal from non-specifically adsorbed biotin probe.

Reaction time and temperature: IEDDA reactions between BCN and tetrazines are fast (second-order rate constants typically in the range of 1–100 M⁻¹s⁻¹ for endo-BCN; exact values depend on the tetrazine substitution pattern). For most applications, 30–60 min at room temperature is sufficient. Shorter incubations may be used for highly reactive tetrazines.

Solvent compatibility: Maintain DMSO content below 1% v/v in aqueous working solutions to avoid cytotoxicity in live-cell experiments and to preserve protein integrity. The PEG4 spacer significantly aids aqueous solubility, but very high concentrations of the probe may still require higher DMSO fractions — dilute accordingly.

Endogenous biotin interference: Some cell types (e.g., liver-derived cells, adipocytes) express high levels of endogenous biotin or biotinylated proteins. Pre-blocking with free avidin or streptavidin prior to applying the endo-BCN-PEG4-Biotin probe can mitigate this issue. Alternatively, consider a non-biotin detection strategy and use endo-BCN-PEG4-Biotin only for pull-down, not imaging, in biotin-rich contexts.

BCN stability: BCN-containing reagents are susceptible to slow hydrolysis upon prolonged exposure to aqueous media at elevated temperatures. Prepare working solutions fresh before each experiment; do not pre-dilute in aqueous buffer and store.

Troubleshooting table:

• Low signal: Increase probe concentration; extend reaction time; verify tetrazine incorporation on the partner molecule; check streptavidin conjugate activity.
• High background: Reduce probe concentration; optimize washing steps; add blocking agent; pre-clear with streptavidin before probe application.
• No reaction: Confirm tetrazine partner was not oxidized or degraded; test both components individually in a small-scale reaction monitored by LC-MS.

Applications Overview

endo-BCN-PEG4-Biotin is a versatile tool suited to a broad range of research applications where bioorthogonal tagging followed by streptavidin-based readout is desired:

• Cell-surface glycan and protein labeling: Cells metabolically or chemically pre-labeled with tetrazine-modified unnatural sugars or amino acids can be rapidly tagged with endo-BCN-PEG4-Biotin, followed by streptavidin-fluorophore staining for flow cytometry or microscopy.
• Antibody and protein conjugation: Tetrazine-functionalized antibodies or nanobodies react with endo-BCN-PEG4-Biotin to introduce a biotin group at a defined site, enabling site-specific biotinylation without targeting lysine residues non-selectively.
• Pull-down and affinity enrichment: Biotinylated ligation products can be captured on streptavidin-magnetic beads or agarose for affinity purification of tetrazine-bearing proteins or their interactors, followed by mass spectrometry identification.
• In vivo pretargeting: In pretargeting strategies, a tetrazine-modified targeting vector (e.g., antibody fragment) is administered first; endo-BCN-PEG4-Biotin is then delivered as a secondary probe to ligate in situ, reducing off-target exposure of the detection moiety.
• ELISA and lateral flow assays: As a secondary labeling reagent, endo-BCN-PEG4-Biotin can convert any tetrazine-tagged detection antibody into a biotinylated antibody compatible with streptavidin-HRP detection systems.

Handling, Storage, and Safety Considerations

Storage: Store endo-BCN-PEG4-Biotin at −20 °C in a tightly sealed vial, protected from light and atmospheric moisture. Under these conditions, the reagent is expected to be stable for at least 12 months from the date of manufacture (verify with the Certificate of Analysis for the specific lot).

Handling: Allow the vial to equilibrate to room temperature before opening to prevent condensation from introducing moisture into the solid or concentrated DMSO stock. Use anhydrous DMSO for reconstitution. Once dissolved, aliquot into single-experiment volumes using low-protein-binding microtubes to minimize adsorption losses.

Disposal: Dispose of endo-BCN-PEG4-Biotin and solutions containing it according to your institution's chemical waste regulations. Although this compound is not classified as a hazardous material under standard research-laboratory classifications (verify with the SDS), treat all laboratory reagents with appropriate caution.

Personal protective equipment: Wear appropriate PPE including nitrile gloves, lab coat, and safety glasses when handling. Avoid inhalation of any fine powder during weighing.

Quality control: Confirm identity and purity of each lot using the Certificate of Analysis (CoA) provided by Aladdin Scientific. Typical characterization includes HPLC purity, mass spectrometry (ESI-MS or MALDI), and NMR. Contact Aladdin Scientific technical support if the CoA data are absent or if analytical results deviate significantly from specifications.

Frequently asked questions

What tetrazine concentration should I use to pair with endo-BCN-PEG4-Biotin?

The optimal tetrazine concentration depends on the specific tetrazine partner and the application context. A typical starting ratio is equimolar or a slight molar excess (1.5–3×) of tetrazine relative to BCN. For cell-surface labeling, titrate both components empirically while monitoring signal-to-background ratio by flow cytometry or microscopy.

Can endo-BCN-PEG4-Biotin be used in live-cell experiments without cytotoxicity concerns?

BCN-based bioorthogonal reagents are generally well tolerated by mammalian cells at the low micromolar concentrations typically used in labeling experiments. The PEG4 spacer further improves biocompatibility by reducing hydrophobicity. However, researchers should keep the DMSO co-solvent below 1% v/v and validate cell viability (e.g., by trypan blue exclusion or MTT assay) under their specific experimental conditions, especially at higher probe concentrations or prolonged exposure times.

What is the difference between endo-BCN and exo-BCN, and why does this product use the endo configuration?

BCN exists as two diastereomers: endo and exo, differing in the orientation of the cyclopropane ring relative to the bicyclic framework. The endo isomer typically exhibits faster IEDDA reaction kinetics with tetrazines compared to the exo isomer due to favorable orbital overlap geometry. This makes endo-BCN reagents preferable when rapid, efficient labeling is required, particularly in live-cell or time-sensitive applications.

How do I confirm that the IEDDA ligation between endo-BCN-PEG4-Biotin and my tetrazine reagent has occurred?

The most straightforward analytical method is LC-MS or MALDI-MS: the ligation product will show a mass corresponding to the sum of both reactants minus the molecular weight of N2 (released during the IEDDA retro reaction). Additionally, tetrazine has a characteristic UV absorbance around 285 nm and pink-to-red color; loss of this absorbance and color upon mixing with BCN indicates successful reaction. For cell-based applications, parallel imaging with streptavidin-fluorophore before and after the reaction serves as a functional confirmation.

Is endo-BCN-PEG4-Biotin compatible with formaldehyde fixation for imaging?

IEDDA ligation using endo-BCN-PEG4-Biotin is best performed on live or freshly harvested cells prior to fixation, as fixation can alter cell permeability and may interfere with streptavidin access to biotinylated targets. If post-fixation labeling is required, optimize streptavidin staining conditions in the fixed context and include appropriate controls to rule out fixation-induced signal artifacts.

References

1. Blackman, M. L.; Royzen, M.; Fox, J. M. Tetrazine ligation: Fast bioconjugation based on inverse-electron-demand Diels-Alder reactivity. J. Am. Chem. Soc. 2008, 130, 13518–13519. doi:10.1021/ja8053805
2. Dommerholt, J.; Schmidt, S.; Temming, R.; Hendriks, L. J. A.; Rutjes, F. P. J. T.; van Hest, J. C. M.; Lefeber, D. J.; Friedl, P.; van Delft, F. L. Readily accessible bicyclononynes for bioorthogonal labeling and three-dimensional imaging of living cells. Angew. Chem. Int. Ed. 2010, 49, 9422–9425. doi:10.1002/anie.201003761
3. Versteegen, R. M.; Rossin, R.; ten Hoeve, W.; Janssen, H. M.; Robillard, M. S. Click to release: Instantaneous doxorubicin elimination upon tetrazine ligation. Angew. Chem. Int. Ed. 2013, 52, 14112–14116. doi:10.1002/anie.201305969
4. Taylor, M. T.; Blackman, M. L.; Dmitrenko, O.; Fox, J. M. Design and synthesis of highly reactive dienophiles for the tetrazine-trans-cyclooctene ligation. J. Am. Chem. Soc. 2011, 133, 9646–9649. doi:10.1021/ja201844c

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.